Entity type
Individual
Filer Snapshot
Carl Walkey
CIK 0001843189. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
29
Latest filing
04 Aug 2022
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for NLTX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
NLTX
02 Aug 2022
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 04 Aug 2022 for CIK 0001843189.
- Business address
- C/O Neoleukin Therapeutics, Inc., 360 1616 Eastlake Avenue East, Seattle, WA, 98102
Filer intelligence
What SEC filings say about Carl Walkey
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for NLTX.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
NLTX
02 Aug 2022 ยท Senior Vice President
Latest update
What changed recently for Carl Walkey
Latest ownership report period: 02 Aug 2022. Open the source-backed page to inspect the fresh filing or facts context.
Update date
04 Aug 2022
Page type
Ownership filings
Latest period
02 Aug 2022
Ownership context was refreshed from SEC Forms 3/4/5 filed on 04 Aug 2022.
SEC filing record
CIK 0001843189 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
29
First seen
02 Feb 2021
Latest filing
04 Aug 2022
Entity
Individual
Observed form types
4
3
CIK-linked evidence first
Latest Filings
Showing the latest 12 of 29 SEC filings for Carl Walkey.
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 04 Aug 2022
- Reporting date
- 02 Aug 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 02 Feb 2022
- Reporting date
- 01 Feb 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 05 Aug 2021
- Reporting date
- 03 Aug 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 17 Jun 2021
- Reporting date
- 16 Jun 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 11 Jun 2021
- Reporting date
- 09 Jun 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 09 Jun 2021
- Reporting date
- 08 Jun 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 07 Jun 2021
- Reporting date
- 04 Jun 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 26 May 2021
- Reporting date
- 26 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 21 May 2021
- Reporting date
- 19 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 12 May 2021
- Reporting date
- 12 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 06 May 2021
- Reporting date
- 05 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 001-36327
FORM 4 SUBMISSION
- Filing date
- 30 Apr 2021
- Reporting date
- 28 Apr 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing